<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02315807</url>
  </required_header>
  <id_info>
    <org_study_id>NeuroCog001</org_study_id>
    <nct_id>NCT02315807</nct_id>
  </id_info>
  <brief_title>Neurostimulation for Cognitive Rehabilitation in Stroke</brief_title>
  <acronym>NeuroCog</acronym>
  <official_title>Neurostimulation for Cognitive Enhancement After Stroke (NeuroCog)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Paraíba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidade Federal do Rio Grande do Norte</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Paraíba</source>
  <brief_summary>
    <textblock>
      Transcranial direct current stimulation has shown promising results in stroke patients. This
      study is a double blind, sham-controlled clinical trial aiming to compare the long-term
      effects of stimulation in two different cognitive regions after a stroke. Sixty patients who
      suffer from chronic strokes will be randomized into 1 of 3 groups: dorsolateral prefrontal
      cortex, cingulo-opercular network and motor primary cortex (control). Each group will receive
      transcranial direct current stimulation for 20 minutes for 10 consecutive working days (2
      weeks). Patients will be assessed with a Dysexecutive Questionnaire, Semantic Fluency test,
      categorical verbal fluency and Go-no go tests, Wechsler Adult Intelligence Scale, Rey
      Auditory-Verbal Learning Test, Letter Comparison and Pattern Comparison Tasks at baseline,
      after their tenth stimulation session (week 2) and endpoint (week 4). Those who achieve
      clinical improvement with neurostimulation will be invited to receive treatment for 12 months
      as part of a follow-up study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Executive Function measured by Dysexecutive Questionnaire (DEX)</measure>
    <time_frame>Change for executive functions at 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Verbal Fluency (Semantic Fluency Test)</measure>
    <time_frame>[ Time Frame: Baseline, Week 2 and Week 4 ]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response inhibition (Go-no-go Test)</measure>
    <time_frame>[ Time Frame: Baseline, Week 2 and Week 4 ]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Executive function (Wechsler Intelligence Scale for Adults)</measure>
    <time_frame>[ Time Frame: Baseline, Week 2 and Week 4 ]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Memory (Rey Auditory Verbal Learning)</measure>
    <time_frame>[ Time Frame: Baseline, Week 2 and Week 4 ]</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Processing Speed (Letter Comparison and Pattern Comparison Tasks)</measure>
    <time_frame>[ Time Frame: Baseline, Week 2 and Week 4 ]</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Stroke</condition>
  <condition>Cognitive Impairment</condition>
  <condition>Cerebral Infarction</condition>
  <arm_group>
    <arm_group_label>dlPFC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in cingulo-opercular network</description>
  </arm_group>
  <arm_group>
    <arm_group_label>M1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in motor primary cortex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <arm_group_label>dlPFC</arm_group_label>
    <arm_group_label>CON</arm_group_label>
    <arm_group_label>M1</arm_group_label>
    <other_name>tdcs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischaemic chronic stroke

          -  Mild/Moderate Cognitive impairment

          -  Informed consent

        Exclusion Criteria:

          -  National Institute of Health Stroke Scale (NIHSS) ≥ 16 points

          -  Severe cognitive comorbidities (dementia, depression)

          -  transcranial direct current stimulation criteria: use of modulators of the Central
             Nervous System drugs; patients with implanted metallic or electronic devices;
             pacemaker; seizures; pregnancy;any other condition that might limit or interfere in
             the sensorimotor system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Suellen Andrade, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Paraíba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suellen Andrade</last_name>
    <email>suellenandrade@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Suellen Andrade</name>
      <address>
        <city>João Pessoa</city>
        <state>PB</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suellen Andrade</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2014</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Paraíba</investigator_affiliation>
    <investigator_full_name>Suellen Marinho Andrade</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

